selexipag
SpainDrugs containing this active substance
-
It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults whose condition is not sufficiently controlled with other medications or who cannot take them.
Form: tablets, film-coated
Active substance Dosage selexipag 1,000 µg Manufacturer: Janssen-Cilag International N.V
-
It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults whose condition is not sufficiently controlled with other medications, or for patients who cannot use those other treatments.
Form: tablets, film-coated
Active substance Dosage selexipag 1,200 µg Manufacturer: Janssen-Cilag International N.V
-
It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults who have not achieved sufficient control with other medications, or it may be used alone if the patient cannot take other PAH treatments.
Form: tablets, film-coated
Active substance Dosage selexipag 1,400 µg Manufacturer: Janssen-Cilag International N.V
-
It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults who are not adequately controlled with other medications, or when they cannot use such medications.
Form: tablets, film-coated
Active substance Dosage selexipag 1,600 µg Manufacturer: Janssen-Cilag International N.V
-
It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults who are not sufficiently controlled with other medications or who cannot take them.
Form: tablets, film-coated
Active substance Dosage selexipag 200 µg Manufacturer: Janssen-Cilag International N.V
-
It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults who are not sufficiently controlled with other medications, or in patients who cannot use such treatments.
Form: tablets, film-coated
Active substance Dosage selexipag 400 µg Manufacturer: Janssen-Cilag International N.V
-
It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults who are not adequately controlled with other medications, or it may be used alone if the patient is not a candidate for other treatments.
Form: tablets, film-coated
Active substance Dosage selexipag 600 µg Manufacturer: Janssen-Cilag International N.V
-
It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults who have not been adequately controlled with other medications, or in patients who cannot use such treatments.
Form: tablets, film-coated
Active substance Dosage selexipag 800 µg Manufacturer: Janssen-Cilag International N.V